BioSpace News Archive

Sonoma Biotherapeutics, Inc. today announced the formation of its scientific advisory board.

Halberd Corporation (OTC PINK:HALB) has announced that preclinical testing is now underway at Mississippi State University (MSU) for its groundbreaking patent-pending nasal spray designed to suppress the negative effects of Traumatic Brain Injury (TBI).

Panbela Therapeutics, Inc. announced that it has regained the North American rights to develop and commercialize Flynpovi and sulindac) in patients with familial adenomatous polyposis, as a result of the termination of the licensing agreement between Cancer Prevention Pharmaceuticals, Inc. and with One-Two Therapeutics Assets Limited.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today that it will present data from 14 studies highlighting advances in precision oncology and cancer screening at the 2023 American Association for Cancer Research (AACR) Annual Meeting.

COTA, Inc.today announced the appointment of Sandy Leonard as its first Chief Commercial Officer.

Bone Biologics Corporation announces that the Human Research Ethics Committee (HREC) has approved Monash Health as the first of a planned multicenter pilot clinical trial to evaluate the Company’s NB1 bone graft in Australia.

MAIA Biotechnology, Inc. (NYSE American: MAIA ) today announced positive topline data from the completed Part A safety lead-in of the Company’s THIO-101 Phase 2 go-to-market trial in advanced Non-Small Cell Lung Cancer (NSCLC) and has commenced recruitment in Part B randomized efficacy/dose selection.

DermTech, Inc. today announced an agreement with a Blues plan in North Carolina.

Veru Inc. today announced results from a preclinical in vitro study evaluating the effects of sabizabulin against prototypical poxvirus, vaccinia virus, which demonstrated that sabizabulin prevented both the release of poxvirus from infected cells and the spread of poxvirus to healthy cells.

Akron Children’s Hospital has been awarded a three-year $1.3 million grant from the National Institutes of Health /National Institute of Nursing Research to better define the practices of high-quality pediatric palliative care, particularly in seeking out the voices of the children, teens and young adults at the center of that care.